LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Bright Minds Biosciences Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERDRUG
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / DRUG COVERAGE

What’s moving Bright Minds Biosciences Inc. now

Current reporting with the operating signal separated from the noise.

01
MarketBeat

Perceptive Advisors LLC Sells 71,746 Shares of Bright Minds Biosciences Inc. $DRUG

Investors are testing whether Bright Minds Biosciences Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
MarketBeat

Janus Henderson Group PLC Raises Holdings in Bright Minds Biosciences Inc. $DRUG

The development tests whether Bright Minds Biosciences Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
03
MarketBeat

Bright Minds Biosciences Inc. $DRUG Shares Bought by Vivo Capital LLC

Investors are testing whether Bright Minds Biosciences Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
MarketBeat

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Rating of "Buy" from Brokerages

The story matters when it changes Bright Minds Biosciences Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest DRUG filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-06-03 · Period 2026-03-31SEC ↗6-KOfficial SEC filingFiled 2026-06-02 · Period 2026-01-20SEC ↗SCHEDULE 13D/AOfficial SEC filingFiled 2026-07-02SEC ↗6-KOfficial SEC filingFiled 2026-05-28 · Period 2026-05-26SEC ↗6-KOfficial SEC filingFiled 2026-05-20 · Period 2026-03-31SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-05-15SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-05-15SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-05-15SEC ↗
EARNINGS / QUARTERLY TRACKER

Bright Minds Biosciences Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.